June 17, 2022 06:38 ET | Source: Research and Markets Research and Markets
Dublin, June 17, 2022 (GLOBE NEWSWIRE) -- The "Global Arthroscopy Devices Market Size, Share & Industry Trends Analysis Report By Type, By Application (Knee Arthroscopy, Hip Arthroscopy, Shoulder & Elbow Arthroscopy), By Regional Outlook and Forecast, 2022-2028" report has been added to ResearchAndMarkets.com's offering. The Global Arthroscopy Devices Market size is expected to reach $28.6 billion by 2028, rising at a market growth of 7.2% CAGR during the forecast period. An arthroscope is a medical instrument that allows doctors to see within bodily joints such as the shoulder, knee, spine, hip, and elbow to inspect, diagnose, and perform therapeutic procedures. Arthroscopy devices can look for illnesses like osteoarthritis, rheumatoid arthritis, tendonitis, and bone tumors in the joints. Furthermore, the use of arthroscopy devices has increased as the frequency of sports-related injuries and the number of sports tournaments has increased. Furthermore, the need for intrusive therapies is increasing across the world. Also, technological improvements have allowed arthroscopy devices to be used for a wide range of bone and joint disorders, resulting in a significant arthroscopy devices market opportunity. As per the World Health Organization, there were 1 billion persons aged 60 and more in 2019, with that number predicted to rise to 1.4 billion by 2030 and 2.1 billion by 2050. As a result, the number of patients with musculoskeletal diseases will rise, which will increase the demand for arthroscopy instruments. Furthermore, 1.71 billion individuals will be affected by musculoskeletal diseases by 2021, making it the biggest cause of disability worldwide. As a result, medical gadgets that can efficiently test and treat bone and joint disorders are in high demand. Moreover, in emerging economies, spending on healthcare facilities is rapidly expanding. According to the India Brand Equity Foundation, India's hospital business is predicted to reach approximately $372 billion in FY22, up from $61.79 billion in FY17, indicating a CAGR of roughly 16-17%. In addition, the use of arthroscopy devices allows patients to recover quickly and with few consequences. COVID-19 Impact Analysis